U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07320443) titled 'Platelet Indices in Inflammatory Bowel Diseases' on Dec. 04, 2025.
Brief Summary: Inflammatory bowel disease (IBD) is a chronic, immune-mediated condition characterized by relapsing inflammation of the gastrointestinal tract. It primarily includes two subtypes: ulcerative colitis (UC) and Crohn's disease (CD), both of which have shown a rising incidence globally over recent decades .The pathogenesis of IBD is complex and multifactorial, involving a dynamic interplay of genetic susceptibility, immune dysregulation, environmental exposures, and gut microbiota alterations .
Recent studies have highlighted the emerging role of platelets...